(Q28373236)
Statements
Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group (English)
0 references
14
0 references
1
0 references
39-45
0 references